Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...

Explore the groundbreaking achievements in quantum as Kipu Quantum and IonQ solve a complex protein folding problem on ...

Explore the exciting advancements in organoids with the successful growth of liver tissue that includes internal blood ...

Explore the link between α2,6-sialyltransferase-I and Alzheimer's disease progression. Understand the new findings on ...

Despite the results, the researchers believe that AI-driven approaches offer a new way forward. Their preprint outlines a ...

Drug discovery often pushes the boundaries of what we understand. John Lepore, MD, CEO of ProFound Therapeutics and CEO-Partner at Flagship Pioneering, is furthering that challenge by redefining where ...

Overcoming a key delivery challenge A long-standing challenge in using lipid nanoparticles (LNPs) is their tendency to accumulate in the liver, where they are filtered out by the reticuloendothelial ...

DARPin therapeutics were a prominent theme at AACR 2025, with Molecular Partners presenting a trio of preclinical programmes spanning radiopharmaceuticals and immune cell engagers. DARPins – designed ...

Explore how GenAI is transforming pharmaceutical clinical trials by reducing manual tasks and enhancing research efficiency.

Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in collaboration with Dana-Farber Cancer Institute at Harvard Medical School, Columbia University ...